Official Title
Woebot for Substance Use Disorders During COVID-19
Brief Summary

The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.

Completed
Substance Use Disorders
Alcohol Use Disorder

Other: Woebot Substance Use Disorder

Woebot Substance Use Disorder is an automated conversational agent, available through a smartphone application, that delivers evidence-based psychotherapeutics, empathy, and emotional health psychoeducation.

Eligibility Criteria

Inclusion Criteria:

- All genders aged 18-65 years

- Access to a smartphone

- Available and committed to engage with app and complete assessments

- Be willing to provide email address (as this is how assessment incentives will be
distributed),

- Literate in English (as W-SUDs conversational and video materials will be in English).

Exclusion Criteria:

- Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of
this population)

- History of severe drug/alcohol use

- History of opioid misuse without medication-assisted treatment

- Suicide attempt within the past year

- Opioid overdose within the past year

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 65 Years
Countries
United States
Locations

Stanford University
Palo Alto, California, United States

Woebot Health
NCT Number
MeSH Terms
Substance-Related Disorders
Alcoholism